Atlas Trials

Hydroxychloroquine in Individuals At-risk for Type 1 Diabetes Mellitus

Clinical trial NCT03428945 · TERMINATED

Trial details

NCT number
NCT03428945
Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Type1 Diabetes Mellitus
Start date
2018-08-15
Primary completion
2022-10-27
Enrollment
273

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.